A detailed history of Truist Financial Corp transactions in Vaxart, Inc. stock. As of the latest transaction made, Truist Financial Corp holds 16,000 shares of VXRT stock, worth $9,600. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,000
Previous 16,000 -0.0%
Holding current value
$9,600
Previous $10,000 30.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 20, 2024

BUY
$0.53 - $1.3 $8,480 - $20,800
16,000 New
16,000 $10,000
Q2 2021

Aug 16, 2021

SELL
$5.06 - $10.78 $154,836 - $329,868
-30,600 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$5.64 - $23.33 $172,584 - $713,898
30,600 New
30,600 $185,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $75.9M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.